Federal Register / Vol. 72, No. 106 / Monday, June 4, 2007 / Notices 30809 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/bsc.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: May 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2752 Filed 6–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors for Basic 

Sciences National Cancer Institute. The 

meeting will be closed to the public as 

indicated below in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Cancer Institute, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors for Basic Sciences National 

Cancer Institute. 

Date: July 9, 2007. 

Time: 9 a.m. to 3 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

National Cancer Institute, 9000 Rockville 

Pike, Building 31, Conference Room 6, 

Bethesda, MD 20892. 

Contact Person: Florence E. Farber, PhD, 

Executive Secretary, Office of the Director, 

National Cancer Institute, National Institutes 

of Health, 6116 Executive Boulevard, Room 

2115, Bethesda, MD 20892, 301–496–7628, 

ff6p@nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: May 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2753 Filed 6–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the President’s Cancer 

Panel, May 24, 2007, 12:30 p.m. to May 

24, 2007, 2:30 p.m. National Institutes of 

Health, 6116 Executive Boulevard, 

Rockville, MD 20852 which was 

published in the Federal Register on 

May 4, 2007, 72 FR 25322. 

This meeting has been rescheduled to 

occur on June 14, 2007 from 9 a.m. to 

10 a.m. The meeting is closed to the 

public. 

Dated: May 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2756 Filed 6–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meetings 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of meetings of the 

National Cancer Institute Clinical Trials 

Advisory Committee. 

The meetings will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Clinical Trials Advisory Committee, 

Coordination Subcommittee. 

Date: July 10, 2007. 

Time: 7 p.m. to 9 p.m. 

Agenda: Provide advice to the Director, 

NCI on how to foster collabration among the 

various components of the NCI-support 

clinical trials infrastructure. 

Place: Pooks Hill Bethesda Marriott, 5151 

Pooks Hill Road, Bethesda, MD 20814. 

Contact Person: Sheila A. Prindiville, MD, 

Director, Coordinating Center for Clinical 

Trials, Office of the Director, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Suite 507, Bethesda, MD 

20892, 301–451–5048, 

prindivs@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Clinical Trials Advisory Committee; 

CTAC. 

Date: July 11, 2007. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: Update on the Clinical Trials 

Working Group Implementation. 

Place: National Institutes of Health, 

Building 31, 6th Floor, C–Wing, 31 Center 

Drive, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Sheila A. Prindiville, MD, 

Director, Coordinating Center for Clinical 

Trials, Office of the Director, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Suite 507, Bethesda, MD 

20892, 301–451–5048, 

prindivs@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 


rwilkins on PROD1PC63 with NOTICES